Skip to main content

Advertisement

SpringerLink
Log in

Concentration of Proteasome in the Blood Plasma of Children with Acute Appendicitis, Before and After Surgery, and Its Correlation with CRP

  • Original Scientific Report
  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Objective

The determination of 20S proteasome concentration in the blood plasma of children with appendicitis and its correlation with CRP.

Design and setting

Thirty-one children with acute appendicitis, were randomly included into the study (age 5 years up to 17 years, mean age 11.5 + 1 years).

Participants

There were 17 girls and 14 boys. Eighteen healthy, age-matched subjects, admitted for planned surgeries served as controls. Exclusion criteria were: severe preexisting infections, immunological or cardiovascular diseases that required long-term medication, and complicated cases of appendicitis with perforation of appendix and/or peritonitis.

Main outcome measures

The 20S proteasome concentrations in the blood plasma of patients with acute appendicitis were highest before the surgery and were above the range of concentrations measured in controls, and the difference was statistically significant.

Results

The 20S proteasome concentration measured 24 and 72 h after the operation, slowly decreased over time, and still did not reach the normal range, when compared with the concentration measured in controls (p < 0.05).

Conclusions

20S proteasome concentration may reflect the metabolic response to acute state inflammation, and the process of gradual ebbing of the inflammation. The method of operation—classic open appendectomy, or laparoscopic appendectomy, does not influence the general trend in 20S proteasome concentration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Brackeva B, De Punt V, Kramer G, Costa O, Verhaeghen K, Stangé G, Sadones J, Xavier C, Aerts JM, Gorus FK, Martens GA (2015) Potential of UCHL1 as biomarker for destruction of pancreatic beta cells. J Proteom 117:156–167

    Article  CAS  Google Scholar 

  2. Wilson CL, Murphy LB, Leslie J, Kendrick S, French J, Fox CR, Sheerin NS, Fisher A, Robinson JH, Tiniakos DG, Gray DA, Oakley F, Mann DA (2015) Ubiquitin C-terminal hydrolase 1: a novel functional marker for liver myofibroblasts and a therapeutic target in chronic liver disease. J Hepatol 63(6):1421–1428

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Hussain S, Bedekovics T, Chesi M, Bergsagel PL, Galardy PJ (2015) UCHL1 is a biomarker of aggressive multiple myeloma required for disease progression. Oncotarget 6(38):40704–40718

    Article  PubMed  PubMed Central  Google Scholar 

  4. Jin Y, Zhang W, Xu J, Wang H, Zhang Z, Chu C, Liu X, Zou Q (2015) UCH-L1 involved in regulating the degradation of EGFR and promoting malignant properties in drug-resistant breast cancer. Int J Clin Exp Pathol 8(10):12500–12508

    PubMed  PubMed Central  CAS  Google Scholar 

  5. Ito WD, Lund N, Zhang Z, Buck F, Lellek H, Horst A, Machens HG, Schunkert H, Schaper W, Meinertz T (2015) Activation of cell surface bound 20S proteasome inhibits vascular cell growth and arteriogenesis. Biomed Res Int 2015:719316

    PubMed  PubMed Central  Google Scholar 

  6. Hochstrasser M (1996) Ubiquitin-dependent protein degradation. Ann Rev Genet 30:405–439

    Article  PubMed  CAS  Google Scholar 

  7. Yu J, Tao Q, Cheung KF, Jin H, Poon FF, Wang X et al (2008) Epigenetic identification of Ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular car-cinoma and other digestive tumors. Hepatology 48(2):508–518

    Article  PubMed  CAS  Google Scholar 

  8. Hussain S, Foreman O, Perkins SL, Witzig TE, Miles RR, Van Deursen J et al (2010) The de-ubiquitinase UCH-L1 is an oncogene that drives the development of lymphoma in vivo by deregulating PHLP P1 and Akt signaling. Leukemia 24(9):1641–1655

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  9. Dieudé M, Bell C, Turgeon J, Beillevaire D, Pomerleau L, Yang B et al (2015) The 20S proteasome core, active within apoptotic exosome-like vesicles, induces autoantibody production and accelerates rejection. Sci Transl Med 7(318):318

    Article  CAS  Google Scholar 

  10. Majetschak M, Perez M, Sorell LT, Lam J, Maldonado ME, Hoffman RW (2008) Circulating 20S proteasome levels in patients with mixed connective tissue disease and systemic lupus erythematosus. Clin Vaccine Immunol 15:1489–1493

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. Henry L, Lavabre-Bertrand T, Douche T, Uttenweiler-Joseph S, Fabbro-Peray P, Monsarrat B et al (2010) Diagnostic value and prognostic significance of plasmatic proteasome level in patients with melanoma. Exp Dermatol 19:1054–1059

    Article  PubMed  CAS  Google Scholar 

  12. Jakob C, Egerer K, Liebisch P, Türkmen S, Zavrski I, Kuckelkorn U et al (2007) Circulating proteasome levels are an independent prognostic factor for survival in multiple myeloma. Blood 109:2100–2105

    Article  PubMed  CAS  Google Scholar 

  13. Matuszczak E, Tylicka M, Debek W, Hermanowicz A, Ostrowska H (2015) The comparison of C-proteasome activity in the plasma of children after burn injury, mild head injury and blunt abdominal trauma. Adv Med Sci 60(2):253–258

    Article  PubMed  Google Scholar 

  14. Tylicka M, Matuszczak E, Dębek W, Hermanowicz A, Ostrowska H (2014) Circulating proteasome activity following mild head injury in children. Childs Nerv Syst 30(7):1191–1196

    Article  PubMed  PubMed Central  Google Scholar 

  15. Matuszczak E, Tylicka M, Dębek W, Hermanowicz A, Ostrowska H (2014) Correlation between circulating proteasome activity, total protein and c-reactive protein levels following burn in children. Burns 40(5):842–847

    Article  PubMed  CAS  Google Scholar 

  16. Sixt SU, Dahlmann B (2008) Extracellular, circulating proteasomes and ubiquitin—incidence and relevance. Biochim Biophys Acta 1782:817–823

    Article  PubMed  CAS  Google Scholar 

  17. Sankiewicz A, Laudański P, Romanowicz L, Hermanowicz A, Roszkowska-Jakimiec W, Debek W et al (2015) Development of surface plasmon resonance imaging biosensors for detection of ubiquitin carboxyl-terminal hydrolase L1. Anal Biochem 469:4–11

    Article  PubMed  CAS  Google Scholar 

  18. Gorodkiewicz E, Ostrowska H, Sankiewicz A (2011) SPR imaging biosensor for the 20S proteasome: sensor development and application to measurement of proteasomes in human blood plasma. Mikrochim Acta 175:177–184

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  19. Gorodkiewicz E (2009) Surface plasmon resonance imaging sensor for cathepsin determination based in immobilized cystatin. Protein Pept Lett 16:1379–1385

    Article  PubMed  CAS  Google Scholar 

  20. Johnsson B, Lofas S, Lindquist G (1991) Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors. Anal Biochem 198:268–277

    Article  PubMed  CAS  Google Scholar 

  21. Gorodkiewicz E, Sankiewicz A, Laudański P (2014) Surface plasmon resonance imaging biosensors for aromatase based on a potent inhibitor and a specific antibody: sensor development and application for biological material. Cent Eur J Chem 12:557–567

    Article  CAS  Google Scholar 

  22. Flück K, Fandrey J (2016) Oxygen sensing in intestinal mucosal inflammation. Pflugers Arch 468(1):77–84

    Article  PubMed  CAS  Google Scholar 

  23. Xu J, Zhou L, Ji L, Chen F, Fortmann K, Zhang K et al (2016) The REGγ-proteasome forms a regulatory circuit with IκBɛ and NFκB in experimental colitis. Nat Commun 7:10761

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  24. Mantovani A et al (2008) Cancer-related inflammation. Nature 454:436–444

    Article  PubMed  CAS  Google Scholar 

  25. Gilmore TD (2006) Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 25(51):6680–6684

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pediatric Surgery Department, Medical University of Bialystok, Waszyngtona 17, 15-274, Bialystok, Poland

    Ewa Matuszczak, Wojciech Dębek & Adam Hermanowicz

  2. Biophysics Department, Medical University of Bialystok, Bialystok, Poland

    Marzena Tylicka

  3. Electrochemistry Department, University of Bialystok, Bialystok, Poland

    Anna Sankiewicz & Ewa Gorodkiewicz

Authors
  1. Ewa Matuszczak
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marzena Tylicka
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wojciech Dębek
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anna Sankiewicz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ewa Gorodkiewicz
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Adam Hermanowicz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ewa Matuszczak.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Matuszczak, E., Tylicka, M., Dębek, W. et al. Concentration of Proteasome in the Blood Plasma of Children with Acute Appendicitis, Before and After Surgery, and Its Correlation with CRP. World J Surg 42, 2259–2264 (2018). https://doi.org/10.1007/s00268-017-4407-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-017-4407-7

Search

Navigation